John Delacourt is Vice President, Legal Affairs of the Plasma Protein Therapeutics Association (“PPTA”). PPTA is a global trade association that represents manufacturers of plasma-derived and recombinant biological therapies, as well as the world’s leading source plasma collectors. Prior to joining PPTA, Mr. Delacourt practiced antitrust law with Kelley Drye & Warren LLP, where he focused on government investigations, litigation, merger review, and corporate counseling. Prior to joining Kelley Drye, Mr. Delacourt served first as Assistant Director (2003), then as Chief Antitrust Counsel (2004-2006), of the Federal Trade Commission’s Office of Policy Planning. Mr. Delacourt is a frequent writer and speaker on health care, pharmaceutical, antitrust, and competition policy topics. He is a graduate of Harvard Law School and Georgetown University.